Patents by Inventor Kenji Oeda

Kenji Oeda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8193146
    Abstract: The present invention relates to a method for improving symptom of mood disorder or its related disorder comprising a step of allowing Gm1 protein and the like to be excessively present in a brain of a mammal, and a non-human mammal, to which the method has been applied, and the like.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: June 5, 2012
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Yasuhiko Takahashi, Kenji Oeda
  • Publication number: 20110129848
    Abstract: A novel protein (Gm1) includes an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein ? subunits and a trimer forming domain conserved among G protein ? subunits. The Gm1 protein is involved in signal transduction via a G protein-coupled receptor (GPCR) stimulation. The Gm1 protein is expressed intensively in human brain, thymus, testes, spleen, small intestine, uterus and heart.
    Type: Application
    Filed: February 1, 2011
    Publication date: June 2, 2011
    Applicant: SUMITOMO CHEMICAL COMPANY, LTD.
    Inventors: Yasuhiko Takahashi, Yasuo Matsumoto, Kenji Oeda
  • Patent number: 7893203
    Abstract: A novel protein (Gm1) includes an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein ? subunits and a trimer forming domain conserved among G protein ? subunits. The Gm1 protein is involved in signal transduction via a G protein-coupled receptor (GPCR) stimulation. The Gm1 protein is expressed intensively in human brain, thymus, testes, spleen, small intestine, uterus and heart. A method for screening for a substance capable of regulating a cellular signal transduction employs a polynucleotide encoding the Gm1 protein.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: February 22, 2011
    Assignee: Sumitomo Chemical Company, Ltd.
    Inventors: Yasuhiko Takahashi, Yasuo Matsumoto, Kenji Oeda
  • Patent number: 7807353
    Abstract: The present invention provides a common marmoset-derived hypoxanthine-guanine phosphoribosyltransferase gene and use thereof.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: October 5, 2010
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Toru Yamada, Kenji Oeda
  • Patent number: 7723567
    Abstract: Raffinose synthase genes coding for proteins capable of producing raffinose by combining a D-galactosyl group through an ?(1?6) bond with a hydroxyl group attached to the carbon atom at position 6 of a D-glucose residue in a sucrose molecule were isolated from various plants. These raffinose synthase genes are useful to change the content of raffinose family oligosaccharides in plants.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: May 25, 2010
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Eijiro Watanabe, Kenji Oeda
  • Publication number: 20090210949
    Abstract: The present invention relates to a method for improving symptom of mood disorder or its related disorder comprising a step of allowing Gm1 protein and the like to be excessively present in a brain of a mammal, and a non-human mammal, to which the method has been applied, and the like.
    Type: Application
    Filed: March 15, 2006
    Publication date: August 20, 2009
    Applicant: SUMITOMO CHEMICAL COMPANY LIMITED
    Inventors: Yasuhiko Takahashi, Kenji Oeda
  • Patent number: 7511191
    Abstract: Raffinose synthase genes coding for proteins capable of producing raffinose by combining a D-galactosyl group through an ?(1?6) bond with a hydroxyl group attached to the carbon atom at position 6 of a D-glucose residue in a sucrose molecule were isolated from various plants. These raffinose synthase genes are useful to change the content of raffinose family oligosaccharides in plants.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: March 31, 2009
    Assignee: Sumitomo Chemical Company Ltd.
    Inventors: Eijiro Watanabe, Kenji Oeda
  • Publication number: 20090042789
    Abstract: The present invention relates to a method for improving symptom of mood disorder or its related disorder comprising a step of allowing activated-type Gm1 protein and the like to be excessively present in a brain of a mammal, and a non-human mammal, to which the method has been applied, and the like.
    Type: Application
    Filed: May 17, 2006
    Publication date: February 12, 2009
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Yasuhiko Takahashi, Kenji Oeda
  • Patent number: 7462453
    Abstract: The present invention provides a common marmoset-derived glyceraldehyde-3-phosphate dehydrogenase gene and use thereof.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: December 9, 2008
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Toru Yamada, Kenji Oeda
  • Publication number: 20080233126
    Abstract: A novel protein (Gm1) includes an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein ? subunits and a trimer forming domain conserved among G protein ? subunits. The Gm1 protein is involved in signal transduction via a G protein-coupled receptor (GPCR) stimulation. The Gm1 protein is expressed intensively in human brain, thymus, testes, spleen, small intestine, uterus and heart. A method for screening for a substance capable of regulating a cellular signal transduction employs a polynucleotide encoding the Gm1 protein.
    Type: Application
    Filed: May 9, 2008
    Publication date: September 25, 2008
    Applicant: SUMITOMO CHEMICAL COMPANY, LTD.
    Inventors: Yasuhiko Takahashi, Yasuo Matsumoto, Kenji Oeda
  • Patent number: 7371541
    Abstract: We identified a novel protein (Gm1) comprising an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein ? subunits and a trimer forming domain conserved among G protein ? subunits. The Gm1 is involved in an signal transduction via a G protein-coupled receptor (GPCR) stimulation. Accordingly, this protein is considered to be a novel G protein. The Gm1 is expressed intensively in human brain, thymus, testes, spleen, small intestine, uterus and heart. We also established a method for screening for a substance capable of regulating a cellular signal transduction employing a polynucleotide encoding the Gm1.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: May 13, 2008
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Yasuhiko Takahashi, Yasuo Matsumoto, Kenji Oeda
  • Publication number: 20080032926
    Abstract: The present invention relates to a knockout non-human animal whose genome comprises a disruption in at least one allele of the PHF3 gene, useful in developing drugs for diseases with the onset of atopic dermatitis or the like; a totipotent cell such as an ES cell which is essential to production of the above non-human animal; use thereof; and so on.
    Type: Application
    Filed: August 9, 2005
    Publication date: February 7, 2008
    Inventors: Yoshikazu Naito, Kenji Oeda, Tokuo Sukata, Yoshifumi Inoue
  • Publication number: 20070178467
    Abstract: The present invention relates to a polynucleotide comprising a nucleotide sequence of a promoter region of a gene encoding ? subunit Gm1 of trimeric G-protein, more specifically, said polynucleotide, wherein the nucleotide sequence of a promoter region is, for example, any of the following nucleotide sequences (1) and (2): (1) the nucleotide sequence of SEQ ID NO: 1, and (2) the nucleotide sequence of the nucleotide numbers 603 to 3871 in the nucleotide sequence of SEQ ID NO: 1 and the like.
    Type: Application
    Filed: March 15, 2005
    Publication date: August 2, 2007
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Yasuhiko Takahashi, Kenji Oeda
  • Patent number: 7202083
    Abstract: Promoters capable of efficiently expressing a gene of interest in plants include (1) either a DNA containing SEQ ID No:1 or SEQ ID No:7, or a biological functional equivalent DNA containing SEQ ID No:1 or SEQ ID No:7 that have modifications in their respective nucleotide sequence provided that each retains more than 90% identity to the nucleotide sequence of any region containing at least 250 bp within SEQ ID No:1 or SEQ ID No:7, respectively. Terminators capable of efficiently expressing a gene of interest in plants include either a DNA containing SEQ ID No:2, or a biological functional equivalent DNA containing a SEQ ID No:2 that has a modified nucleotide sequence provided that it retains more than 90% identity to the nucleotide sequence of any region containing at least 250 bp within SEQ ID No:2.
    Type: Grant
    Filed: September 28, 1999
    Date of Patent: April 10, 2007
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Satomi Nishikawa, Kenji Oeda
  • Patent number: 7192712
    Abstract: The present invention provides a common marmoset-derived beta-actin gene and use thereof.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: March 20, 2007
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Toru Yamada, Kenji Oeda
  • Publication number: 20060019283
    Abstract: The present invention provides a common marmoset-derived hypoxanthine-guanine phosphoribosyltransferase gene and use thereof.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Inventors: Toru Yamada, Kenji Oeda
  • Publication number: 20050266474
    Abstract: The present invention provides a common marmoset-derived glyceraldehyde-3-phosphate dehydrogenase gene and use thereof.
    Type: Application
    Filed: June 1, 2005
    Publication date: December 1, 2005
    Inventors: Toru Yamada, Kenji Oeda
  • Publication number: 20050266471
    Abstract: The present invention provides a common marmoset-derived beta-actin gene and use thereof.
    Type: Application
    Filed: May 27, 2005
    Publication date: December 1, 2005
    Inventors: Toru Yamada, Kenji Oeda
  • Publication number: 20050260595
    Abstract: We identified a novel protein (Gm1) comprising an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein ? subunits and a trimer forming domain conserved among G protein ? subunits. The Gm1 is involved in an signal transduction via a G protein-coupled receptor (GPCR) stimulation. Accordingly, this protein is considered to be a novel G protein. The Gm1 is expressed intensively in human brain, thymus, testes, spleen, small intestine, uterus and heart. We also established a method for screening for a substance capable of regulating a cellular signal transduction employing a polynucleotide encoding the Gm1.
    Type: Application
    Filed: July 11, 2003
    Publication date: November 24, 2005
    Inventors: Yasuhiko Takahashi, Yasuo Matsumoto, Kenji Oeda
  • Patent number: 6337430
    Abstract: The present invention provides a promoter including the following DNA (a) or (b): (a) the DNA consisting of the nucleotide sequence of nucleotide numbers 1743 to 2301 in the nucleotide sequence represented by SEQ ID: No. 1; or, (b) the DNA which can be hybridized with said DNA (a) in a stringent condition and having a promoter function in a plant cell, and the like.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: January 8, 2002
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Fumiharu Ishige, Eijiro Watanabe, Kenji Oeda